Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Temozolomide × 90 days × Clear all

Sponsor

Conditions

Glioblastoma 48 Glioma 14 Brain Neoplasms 14 Neuroblastoma 10 Sarcoma, Ewing 8 Gliosarcoma 8 Astrocytoma 8 Medulloblastoma 7 Sarcoma 6 Rhabdomyosarcoma 6 Ependymoma 6 Recurrence 5 Osteosarcoma 5 Neoplasms 5 Melanoma 5 Diffuse Intrinsic Pontine Glioma 4 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Oligodendroglioma 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, Follicular 2

Interventions

Carboplatin 5 pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 fludarabine phosphate 2 Taxes 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Paclitaxel 2 Cyclophosphamide 2 Biopsy 2 veliparib 1 methoxyamine 1 fludarabine 1 durvalumab 1 dapagliflozin 1 capmatinib 1 aldesleukin 1 Standard of Care 1 Smoking Devices 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Practice Guidelines as Topic 1 Platinum 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡